SCHEDULE Follow Up Visit 5-7 yr

NCT02864706 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Transplantation

Interventions

DRUG: Everolimus
DRUG: Cyclosporine
DRUG: Mycophenolate mofetil
DRUG: Corticosteroids

Sponsor

Novartis Pharmaceuticals